nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—HTR7—vas deferens—testicular cancer	0.0572	0.386	CbGeAlD
Maprotiline—ABCB1—Dactinomycin—testicular cancer	0.0402	0.195	CbGbCtD
Maprotiline—CYP1A2—Etoposide—testicular cancer	0.0259	0.126	CbGbCtD
Maprotiline—ABCB1—Vinblastine—testicular cancer	0.0252	0.122	CbGbCtD
Maprotiline—HTR7—vein—testicular cancer	0.0243	0.164	CbGeAlD
Maprotiline—CYP2D6—Vinblastine—testicular cancer	0.0237	0.115	CbGbCtD
Maprotiline—ABCB1—Cisplatin—testicular cancer	0.0231	0.112	CbGbCtD
Maprotiline—ABCB1—Etoposide—testicular cancer	0.0227	0.11	CbGbCtD
Maprotiline—ABCB1—Doxorubicin—testicular cancer	0.0155	0.0752	CbGbCtD
Maprotiline—HTR2A—vein—testicular cancer	0.0152	0.102	CbGeAlD
Maprotiline—ABCB1—Methotrexate—testicular cancer	0.015	0.0728	CbGbCtD
Maprotiline—CYP2D6—Doxorubicin—testicular cancer	0.0146	0.0708	CbGbCtD
Maprotiline—CHRM4—testis—testicular cancer	0.00541	0.0365	CbGeAlD
Maprotiline—SLC6A2—gonad—testicular cancer	0.00324	0.0218	CbGeAlD
Maprotiline—HTR7—gonad—testicular cancer	0.00312	0.0211	CbGeAlD
Maprotiline—SLC6A3—testis—testicular cancer	0.00289	0.0195	CbGeAlD
Maprotiline—HTR2A—embryo—testicular cancer	0.00287	0.0193	CbGeAlD
Maprotiline—CHRM3—female gonad—testicular cancer	0.00267	0.018	CbGeAlD
Maprotiline—CHRM3—testis—testicular cancer	0.00236	0.0159	CbGeAlD
Maprotiline—SLC6A2—testis—testicular cancer	0.00233	0.0157	CbGeAlD
Maprotiline—ORM1—lymph node—testicular cancer	0.00226	0.0152	CbGeAlD
Maprotiline—HTR7—testis—testicular cancer	0.00225	0.0152	CbGeAlD
Maprotiline—DRD2—testis—testicular cancer	0.00213	0.0143	CbGeAlD
Maprotiline—HTR2A—gonad—testicular cancer	0.00195	0.0131	CbGeAlD
Maprotiline—HRH1—female gonad—testicular cancer	0.00189	0.0128	CbGeAlD
Maprotiline—ABCB1—embryo—testicular cancer	0.00188	0.0127	CbGeAlD
Maprotiline—ABCB1—seminal vesicle—testicular cancer	0.00177	0.0119	CbGeAlD
Maprotiline—SLC6A2—lymph node—testicular cancer	0.00169	0.0114	CbGeAlD
Maprotiline—HRH1—testis—testicular cancer	0.00168	0.0113	CbGeAlD
Maprotiline—CYP2D6—female gonad—testicular cancer	0.00144	0.00972	CbGeAlD
Maprotiline—HTR2A—testis—testicular cancer	0.0014	0.00946	CbGeAlD
Maprotiline—CYP2D6—testis—testicular cancer	0.00128	0.00862	CbGeAlD
Maprotiline—ABCB1—gonad—testicular cancer	0.00128	0.0086	CbGeAlD
Maprotiline—HRH1—lymph node—testicular cancer	0.00122	0.00821	CbGeAlD
Maprotiline—ABCB1—female gonad—testicular cancer	0.00104	0.00699	CbGeAlD
Maprotiline—ABCB1—testis—testicular cancer	0.00092	0.0062	CbGeAlD
Maprotiline—Erectile dysfunction—Methotrexate—testicular cancer	0.000727	0.00112	CcSEcCtD
Maprotiline—Hyperhidrosis—Etoposide—testicular cancer	0.000724	0.00112	CcSEcCtD
Maprotiline—Orthostatic hypotension—Doxorubicin—testicular cancer	0.000722	0.00112	CcSEcCtD
Maprotiline—Photosensitivity reaction—Methotrexate—testicular cancer	0.00072	0.00111	CcSEcCtD
Maprotiline—Breast disorder—Doxorubicin—testicular cancer	0.000714	0.00111	CcSEcCtD
Maprotiline—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000712	0.0011	CcSEcCtD
Maprotiline—Diarrhoea—Dactinomycin—testicular cancer	0.000708	0.0011	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000706	0.00109	CcSEcCtD
Maprotiline—Vomiting—Bleomycin—testicular cancer	0.000705	0.00109	CcSEcCtD
Maprotiline—Infestation—Methotrexate—testicular cancer	0.000703	0.00109	CcSEcCtD
Maprotiline—Infestation NOS—Methotrexate—testicular cancer	0.000703	0.00109	CcSEcCtD
Maprotiline—Drowsiness—Methotrexate—testicular cancer	0.000703	0.00109	CcSEcCtD
Maprotiline—Pancytopenia—Epirubicin—testicular cancer	0.000701	0.00109	CcSEcCtD
Maprotiline—Hypotension—Etoposide—testicular cancer	0.0007	0.00108	CcSEcCtD
Maprotiline—Rash—Bleomycin—testicular cancer	0.0007	0.00108	CcSEcCtD
Maprotiline—Dermatitis—Bleomycin—testicular cancer	0.000699	0.00108	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000697	0.00108	CcSEcCtD
Maprotiline—Muscular weakness—Doxorubicin—testicular cancer	0.000697	0.00108	CcSEcCtD
Maprotiline—Stomatitis—Methotrexate—testicular cancer	0.000686	0.00106	CcSEcCtD
Maprotiline—Dysphagia—Doxorubicin—testicular cancer	0.000683	0.00106	CcSEcCtD
Maprotiline—Pollakiuria—Epirubicin—testicular cancer	0.000682	0.00106	CcSEcCtD
Maprotiline—Asthenia—Ifosfamide—testicular cancer	0.00068	0.00105	CcSEcCtD
Maprotiline—Eosinophilia—Doxorubicin—testicular cancer	0.000676	0.00105	CcSEcCtD
Maprotiline—Photosensitivity reaction—Epirubicin—testicular cancer	0.000674	0.00104	CcSEcCtD
Maprotiline—Feeling abnormal—Cisplatin—testicular cancer	0.000674	0.00104	CcSEcCtD
Maprotiline—Paraesthesia—Etoposide—testicular cancer	0.000672	0.00104	CcSEcCtD
Maprotiline—Weight increased—Epirubicin—testicular cancer	0.000672	0.00104	CcSEcCtD
Maprotiline—Pruritus—Ifosfamide—testicular cancer	0.000671	0.00104	CcSEcCtD
Maprotiline—Weight decreased—Epirubicin—testicular cancer	0.000668	0.00103	CcSEcCtD
Maprotiline—ABCB1—lymph node—testicular cancer	0.000667	0.00449	CbGeAlD
Maprotiline—Somnolence—Etoposide—testicular cancer	0.000666	0.00103	CcSEcCtD
Maprotiline—Hepatobiliary disease—Methotrexate—testicular cancer	0.000665	0.00103	CcSEcCtD
Maprotiline—Nausea—Bleomycin—testicular cancer	0.000659	0.00102	CcSEcCtD
Maprotiline—Infestation—Epirubicin—testicular cancer	0.000658	0.00102	CcSEcCtD
Maprotiline—Infestation NOS—Epirubicin—testicular cancer	0.000658	0.00102	CcSEcCtD
Maprotiline—Drowsiness—Epirubicin—testicular cancer	0.000658	0.00102	CcSEcCtD
Maprotiline—Vomiting—Dactinomycin—testicular cancer	0.000658	0.00102	CcSEcCtD
Maprotiline—Agranulocytosis—Methotrexate—testicular cancer	0.000656	0.00102	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000653	0.00101	CcSEcCtD
Maprotiline—Rash—Dactinomycin—testicular cancer	0.000652	0.00101	CcSEcCtD
Maprotiline—Diarrhoea—Ifosfamide—testicular cancer	0.000649	0.001	CcSEcCtD
Maprotiline—Pancytopenia—Doxorubicin—testicular cancer	0.000649	0.001	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Etoposide—testicular cancer	0.000647	0.001	CcSEcCtD
Maprotiline—Body temperature increased—Cisplatin—testicular cancer	0.000646	0.001	CcSEcCtD
Maprotiline—Fatigue—Etoposide—testicular cancer	0.000646	0.000999	CcSEcCtD
Maprotiline—Neuropathy peripheral—Epirubicin—testicular cancer	0.000645	0.000999	CcSEcCtD
Maprotiline—Jaundice—Epirubicin—testicular cancer	0.000642	0.000993	CcSEcCtD
Maprotiline—Stomatitis—Epirubicin—testicular cancer	0.000642	0.000993	CcSEcCtD
Maprotiline—Constipation—Etoposide—testicular cancer	0.00064	0.000991	CcSEcCtD
Maprotiline—Hepatitis—Methotrexate—testicular cancer	0.000631	0.000977	CcSEcCtD
Maprotiline—Pollakiuria—Doxorubicin—testicular cancer	0.000631	0.000977	CcSEcCtD
Maprotiline—Dizziness—Ifosfamide—testicular cancer	0.000627	0.000971	CcSEcCtD
Maprotiline—Urinary tract disorder—Methotrexate—testicular cancer	0.000624	0.000965	CcSEcCtD
Maprotiline—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000623	0.000965	CcSEcCtD
Maprotiline—Hepatobiliary disease—Epirubicin—testicular cancer	0.000623	0.000964	CcSEcCtD
Maprotiline—Weight increased—Doxorubicin—testicular cancer	0.000622	0.000962	CcSEcCtD
Maprotiline—Urethral disorder—Methotrexate—testicular cancer	0.000619	0.000958	CcSEcCtD
Maprotiline—Weight decreased—Doxorubicin—testicular cancer	0.000618	0.000957	CcSEcCtD
Maprotiline—Feeling abnormal—Etoposide—testicular cancer	0.000617	0.000955	CcSEcCtD
Maprotiline—Nausea—Dactinomycin—testicular cancer	0.000615	0.000951	CcSEcCtD
Maprotiline—Agranulocytosis—Epirubicin—testicular cancer	0.000614	0.000951	CcSEcCtD
Maprotiline—Gastrointestinal pain—Etoposide—testicular cancer	0.000612	0.000948	CcSEcCtD
Maprotiline—Infestation—Doxorubicin—testicular cancer	0.000609	0.000943	CcSEcCtD
Maprotiline—Infestation NOS—Doxorubicin—testicular cancer	0.000609	0.000943	CcSEcCtD
Maprotiline—Drowsiness—Doxorubicin—testicular cancer	0.000609	0.000943	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000604	0.000935	CcSEcCtD
Maprotiline—Vomiting—Ifosfamide—testicular cancer	0.000603	0.000933	CcSEcCtD
Maprotiline—Rash—Ifosfamide—testicular cancer	0.000598	0.000925	CcSEcCtD
Maprotiline—Dermatitis—Ifosfamide—testicular cancer	0.000597	0.000925	CcSEcCtD
Maprotiline—Erythema multiforme—Methotrexate—testicular cancer	0.000597	0.000924	CcSEcCtD
Maprotiline—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000597	0.000924	CcSEcCtD
Maprotiline—Urticaria—Etoposide—testicular cancer	0.000595	0.000921	CcSEcCtD
Maprotiline—Stomatitis—Doxorubicin—testicular cancer	0.000594	0.000919	CcSEcCtD
Maprotiline—Jaundice—Doxorubicin—testicular cancer	0.000594	0.000919	CcSEcCtD
Maprotiline—Abdominal pain—Etoposide—testicular cancer	0.000592	0.000916	CcSEcCtD
Maprotiline—Body temperature increased—Etoposide—testicular cancer	0.000592	0.000916	CcSEcCtD
Maprotiline—Hepatitis—Epirubicin—testicular cancer	0.000591	0.000915	CcSEcCtD
Maprotiline—Eye disorder—Methotrexate—testicular cancer	0.00059	0.000913	CcSEcCtD
Maprotiline—Tinnitus—Methotrexate—testicular cancer	0.000589	0.000911	CcSEcCtD
Maprotiline—Hypoaesthesia—Epirubicin—testicular cancer	0.000588	0.00091	CcSEcCtD
Maprotiline—Asthenia—Cisplatin—testicular cancer	0.000587	0.000908	CcSEcCtD
Maprotiline—Cardiac disorder—Methotrexate—testicular cancer	0.000586	0.000907	CcSEcCtD
Maprotiline—Urinary tract disorder—Epirubicin—testicular cancer	0.000584	0.000903	CcSEcCtD
Maprotiline—Urethral disorder—Epirubicin—testicular cancer	0.000579	0.000897	CcSEcCtD
Maprotiline—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000576	0.000892	CcSEcCtD
Maprotiline—Angiopathy—Methotrexate—testicular cancer	0.000573	0.000887	CcSEcCtD
Maprotiline—Mediastinal disorder—Methotrexate—testicular cancer	0.000569	0.000881	CcSEcCtD
Maprotiline—Agranulocytosis—Doxorubicin—testicular cancer	0.000568	0.00088	CcSEcCtD
Maprotiline—Nausea—Ifosfamide—testicular cancer	0.000563	0.000872	CcSEcCtD
Maprotiline—Diarrhoea—Cisplatin—testicular cancer	0.000559	0.000866	CcSEcCtD
Maprotiline—Erythema multiforme—Epirubicin—testicular cancer	0.000559	0.000865	CcSEcCtD
Maprotiline—Alopecia—Methotrexate—testicular cancer	0.000558	0.000864	CcSEcCtD
Maprotiline—Eye disorder—Epirubicin—testicular cancer	0.000552	0.000855	CcSEcCtD
Maprotiline—Tinnitus—Epirubicin—testicular cancer	0.000551	0.000853	CcSEcCtD
Maprotiline—Malnutrition—Methotrexate—testicular cancer	0.00055	0.000851	CcSEcCtD
Maprotiline—Flushing—Epirubicin—testicular cancer	0.000548	0.000849	CcSEcCtD
Maprotiline—Cardiac disorder—Epirubicin—testicular cancer	0.000548	0.000849	CcSEcCtD
Maprotiline—Hepatitis—Doxorubicin—testicular cancer	0.000547	0.000846	CcSEcCtD
Maprotiline—Hypoaesthesia—Doxorubicin—testicular cancer	0.000544	0.000842	CcSEcCtD
Maprotiline—Urinary tract disorder—Doxorubicin—testicular cancer	0.00054	0.000836	CcSEcCtD
Maprotiline—Dysgeusia—Methotrexate—testicular cancer	0.000538	0.000833	CcSEcCtD
Maprotiline—Asthenia—Etoposide—testicular cancer	0.000537	0.000832	CcSEcCtD
Maprotiline—Angiopathy—Epirubicin—testicular cancer	0.000536	0.00083	CcSEcCtD
Maprotiline—Urethral disorder—Doxorubicin—testicular cancer	0.000536	0.00083	CcSEcCtD
Maprotiline—Mediastinal disorder—Epirubicin—testicular cancer	0.000533	0.000824	CcSEcCtD
Maprotiline—Pruritus—Etoposide—testicular cancer	0.00053	0.00082	CcSEcCtD
Maprotiline—Arrhythmia—Epirubicin—testicular cancer	0.000528	0.000817	CcSEcCtD
Maprotiline—Alopecia—Epirubicin—testicular cancer	0.000522	0.000808	CcSEcCtD
Maprotiline—Vomiting—Cisplatin—testicular cancer	0.00052	0.000805	CcSEcCtD
Maprotiline—Vision blurred—Methotrexate—testicular cancer	0.000518	0.000802	CcSEcCtD
Maprotiline—Erythema multiforme—Doxorubicin—testicular cancer	0.000517	0.0008	CcSEcCtD
Maprotiline—Rash—Cisplatin—testicular cancer	0.000515	0.000798	CcSEcCtD
Maprotiline—Dermatitis—Cisplatin—testicular cancer	0.000515	0.000797	CcSEcCtD
Maprotiline—Malnutrition—Epirubicin—testicular cancer	0.000514	0.000796	CcSEcCtD
Maprotiline—Diarrhoea—Etoposide—testicular cancer	0.000512	0.000793	CcSEcCtD
Maprotiline—Eye disorder—Doxorubicin—testicular cancer	0.000511	0.000791	CcSEcCtD
Maprotiline—Tinnitus—Doxorubicin—testicular cancer	0.00051	0.000789	CcSEcCtD
Maprotiline—Cardiac disorder—Doxorubicin—testicular cancer	0.000507	0.000785	CcSEcCtD
Maprotiline—Flushing—Doxorubicin—testicular cancer	0.000507	0.000785	CcSEcCtD
Maprotiline—Tension—Epirubicin—testicular cancer	0.000505	0.000781	CcSEcCtD
Maprotiline—Dysgeusia—Epirubicin—testicular cancer	0.000504	0.00078	CcSEcCtD
Maprotiline—Nervousness—Epirubicin—testicular cancer	0.0005	0.000773	CcSEcCtD
Maprotiline—Angiopathy—Doxorubicin—testicular cancer	0.000496	0.000768	CcSEcCtD
Maprotiline—Dizziness—Etoposide—testicular cancer	0.000495	0.000767	CcSEcCtD
Maprotiline—Mediastinal disorder—Doxorubicin—testicular cancer	0.000493	0.000763	CcSEcCtD
Maprotiline—Leukopenia—Methotrexate—testicular cancer	0.000492	0.000762	CcSEcCtD
Maprotiline—Arrhythmia—Doxorubicin—testicular cancer	0.000488	0.000756	CcSEcCtD
Maprotiline—Nausea—Cisplatin—testicular cancer	0.000486	0.000752	CcSEcCtD
Maprotiline—Vision blurred—Epirubicin—testicular cancer	0.000485	0.00075	CcSEcCtD
Maprotiline—Alopecia—Doxorubicin—testicular cancer	0.000483	0.000748	CcSEcCtD
Maprotiline—Convulsion—Methotrexate—testicular cancer	0.000476	0.000737	CcSEcCtD
Maprotiline—Vomiting—Etoposide—testicular cancer	0.000476	0.000737	CcSEcCtD
Maprotiline—Malnutrition—Doxorubicin—testicular cancer	0.000476	0.000737	CcSEcCtD
Maprotiline—Agitation—Epirubicin—testicular cancer	0.000473	0.000732	CcSEcCtD
Maprotiline—Rash—Etoposide—testicular cancer	0.000472	0.000731	CcSEcCtD
Maprotiline—Dermatitis—Etoposide—testicular cancer	0.000472	0.00073	CcSEcCtD
Maprotiline—Headache—Etoposide—testicular cancer	0.000469	0.000726	CcSEcCtD
Maprotiline—Tension—Doxorubicin—testicular cancer	0.000467	0.000723	CcSEcCtD
Maprotiline—Dysgeusia—Doxorubicin—testicular cancer	0.000466	0.000721	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000465	0.000719	CcSEcCtD
Maprotiline—Nervousness—Doxorubicin—testicular cancer	0.000462	0.000716	CcSEcCtD
Maprotiline—Syncope—Epirubicin—testicular cancer	0.000461	0.000714	CcSEcCtD
Maprotiline—Leukopenia—Epirubicin—testicular cancer	0.00046	0.000713	CcSEcCtD
Maprotiline—Palpitations—Epirubicin—testicular cancer	0.000455	0.000704	CcSEcCtD
Maprotiline—Confusional state—Methotrexate—testicular cancer	0.000452	0.0007	CcSEcCtD
Maprotiline—Loss of consciousness—Epirubicin—testicular cancer	0.000452	0.0007	CcSEcCtD
Maprotiline—Vision blurred—Doxorubicin—testicular cancer	0.000449	0.000694	CcSEcCtD
Maprotiline—Convulsion—Epirubicin—testicular cancer	0.000446	0.00069	CcSEcCtD
Maprotiline—Infection—Methotrexate—testicular cancer	0.000446	0.00069	CcSEcCtD
Maprotiline—Nausea—Etoposide—testicular cancer	0.000445	0.000689	CcSEcCtD
Maprotiline—Hypertension—Epirubicin—testicular cancer	0.000444	0.000687	CcSEcCtD
Maprotiline—Nervous system disorder—Methotrexate—testicular cancer	0.00044	0.000681	CcSEcCtD
Maprotiline—Thrombocytopenia—Methotrexate—testicular cancer	0.000439	0.00068	CcSEcCtD
Maprotiline—Agitation—Doxorubicin—testicular cancer	0.000437	0.000677	CcSEcCtD
Maprotiline—Anxiety—Epirubicin—testicular cancer	0.000436	0.000676	CcSEcCtD
Maprotiline—Skin disorder—Methotrexate—testicular cancer	0.000436	0.000674	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000435	0.000673	CcSEcCtD
Maprotiline—Hyperhidrosis—Methotrexate—testicular cancer	0.000434	0.000671	CcSEcCtD
Maprotiline—Dry mouth—Epirubicin—testicular cancer	0.000428	0.000663	CcSEcCtD
Maprotiline—Syncope—Doxorubicin—testicular cancer	0.000427	0.000661	CcSEcCtD
Maprotiline—Leukopenia—Doxorubicin—testicular cancer	0.000426	0.000659	CcSEcCtD
Maprotiline—Confusional state—Epirubicin—testicular cancer	0.000423	0.000655	CcSEcCtD
Maprotiline—Palpitations—Doxorubicin—testicular cancer	0.000421	0.000651	CcSEcCtD
Maprotiline—Oedema—Epirubicin—testicular cancer	0.00042	0.00065	CcSEcCtD
Maprotiline—Hypotension—Methotrexate—testicular cancer	0.000419	0.000649	CcSEcCtD
Maprotiline—Loss of consciousness—Doxorubicin—testicular cancer	0.000418	0.000648	CcSEcCtD
Maprotiline—Infection—Epirubicin—testicular cancer	0.000417	0.000646	CcSEcCtD
Maprotiline—Shock—Epirubicin—testicular cancer	0.000413	0.000639	CcSEcCtD
Maprotiline—Convulsion—Doxorubicin—testicular cancer	0.000412	0.000638	CcSEcCtD
Maprotiline—Nervous system disorder—Epirubicin—testicular cancer	0.000412	0.000637	CcSEcCtD
Maprotiline—Thrombocytopenia—Epirubicin—testicular cancer	0.000411	0.000636	CcSEcCtD
Maprotiline—Hypertension—Doxorubicin—testicular cancer	0.000411	0.000636	CcSEcCtD
Maprotiline—Tachycardia—Epirubicin—testicular cancer	0.00041	0.000634	CcSEcCtD
Maprotiline—Skin disorder—Epirubicin—testicular cancer	0.000408	0.000631	CcSEcCtD
Maprotiline—Hyperhidrosis—Epirubicin—testicular cancer	0.000406	0.000628	CcSEcCtD
Maprotiline—Insomnia—Methotrexate—testicular cancer	0.000406	0.000628	CcSEcCtD
Maprotiline—Anxiety—Doxorubicin—testicular cancer	0.000404	0.000625	CcSEcCtD
Maprotiline—Paraesthesia—Methotrexate—testicular cancer	0.000403	0.000624	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000402	0.000623	CcSEcCtD
Maprotiline—Somnolence—Methotrexate—testicular cancer	0.000399	0.000617	CcSEcCtD
Maprotiline—Dry mouth—Doxorubicin—testicular cancer	0.000396	0.000613	CcSEcCtD
Maprotiline—Dyspepsia—Methotrexate—testicular cancer	0.000395	0.000611	CcSEcCtD
Maprotiline—Hypotension—Epirubicin—testicular cancer	0.000392	0.000607	CcSEcCtD
Maprotiline—Confusional state—Doxorubicin—testicular cancer	0.000392	0.000606	CcSEcCtD
Maprotiline—Oedema—Doxorubicin—testicular cancer	0.000388	0.000601	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000387	0.000599	CcSEcCtD
Maprotiline—Fatigue—Methotrexate—testicular cancer	0.000387	0.000599	CcSEcCtD
Maprotiline—Infection—Doxorubicin—testicular cancer	0.000386	0.000597	CcSEcCtD
Maprotiline—Shock—Doxorubicin—testicular cancer	0.000382	0.000592	CcSEcCtD
Maprotiline—Nervous system disorder—Doxorubicin—testicular cancer	0.000381	0.00059	CcSEcCtD
Maprotiline—Thrombocytopenia—Doxorubicin—testicular cancer	0.00038	0.000589	CcSEcCtD
Maprotiline—Insomnia—Epirubicin—testicular cancer	0.00038	0.000588	CcSEcCtD
Maprotiline—Tachycardia—Doxorubicin—testicular cancer	0.000379	0.000587	CcSEcCtD
Maprotiline—Skin disorder—Doxorubicin—testicular cancer	0.000377	0.000584	CcSEcCtD
Maprotiline—Paraesthesia—Epirubicin—testicular cancer	0.000377	0.000584	CcSEcCtD
Maprotiline—Hyperhidrosis—Doxorubicin—testicular cancer	0.000375	0.000581	CcSEcCtD
Maprotiline—Somnolence—Epirubicin—testicular cancer	0.000373	0.000578	CcSEcCtD
Maprotiline—Feeling abnormal—Methotrexate—testicular cancer	0.00037	0.000572	CcSEcCtD
Maprotiline—Dyspepsia—Epirubicin—testicular cancer	0.00037	0.000572	CcSEcCtD
Maprotiline—Gastrointestinal pain—Methotrexate—testicular cancer	0.000367	0.000568	CcSEcCtD
Maprotiline—Hypotension—Doxorubicin—testicular cancer	0.000363	0.000562	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000362	0.000561	CcSEcCtD
Maprotiline—Fatigue—Epirubicin—testicular cancer	0.000362	0.00056	CcSEcCtD
Maprotiline—Constipation—Epirubicin—testicular cancer	0.000359	0.000556	CcSEcCtD
Maprotiline—Urticaria—Methotrexate—testicular cancer	0.000356	0.000552	CcSEcCtD
Maprotiline—Abdominal pain—Methotrexate—testicular cancer	0.000355	0.000549	CcSEcCtD
Maprotiline—Body temperature increased—Methotrexate—testicular cancer	0.000355	0.000549	CcSEcCtD
Maprotiline—Insomnia—Doxorubicin—testicular cancer	0.000351	0.000544	CcSEcCtD
Maprotiline—Paraesthesia—Doxorubicin—testicular cancer	0.000349	0.00054	CcSEcCtD
Maprotiline—Feeling abnormal—Epirubicin—testicular cancer	0.000346	0.000535	CcSEcCtD
Maprotiline—Somnolence—Doxorubicin—testicular cancer	0.000345	0.000535	CcSEcCtD
Maprotiline—Gastrointestinal pain—Epirubicin—testicular cancer	0.000343	0.000531	CcSEcCtD
Maprotiline—Dyspepsia—Doxorubicin—testicular cancer	0.000342	0.000529	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000335	0.000519	CcSEcCtD
Maprotiline—Fatigue—Doxorubicin—testicular cancer	0.000335	0.000518	CcSEcCtD
Maprotiline—Urticaria—Epirubicin—testicular cancer	0.000333	0.000516	CcSEcCtD
Maprotiline—Constipation—Doxorubicin—testicular cancer	0.000332	0.000514	CcSEcCtD
Maprotiline—Body temperature increased—Epirubicin—testicular cancer	0.000332	0.000514	CcSEcCtD
Maprotiline—Abdominal pain—Epirubicin—testicular cancer	0.000332	0.000514	CcSEcCtD
Maprotiline—Asthenia—Methotrexate—testicular cancer	0.000322	0.000498	CcSEcCtD
Maprotiline—Feeling abnormal—Doxorubicin—testicular cancer	0.00032	0.000495	CcSEcCtD
Maprotiline—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000318	0.000492	CcSEcCtD
Maprotiline—Pruritus—Methotrexate—testicular cancer	0.000317	0.000491	CcSEcCtD
Maprotiline—Urticaria—Doxorubicin—testicular cancer	0.000309	0.000478	CcSEcCtD
Maprotiline—Abdominal pain—Doxorubicin—testicular cancer	0.000307	0.000475	CcSEcCtD
Maprotiline—Body temperature increased—Doxorubicin—testicular cancer	0.000307	0.000475	CcSEcCtD
Maprotiline—Diarrhoea—Methotrexate—testicular cancer	0.000307	0.000475	CcSEcCtD
Maprotiline—Asthenia—Epirubicin—testicular cancer	0.000301	0.000466	CcSEcCtD
Maprotiline—Pruritus—Epirubicin—testicular cancer	0.000297	0.00046	CcSEcCtD
Maprotiline—Dizziness—Methotrexate—testicular cancer	0.000297	0.000459	CcSEcCtD
Maprotiline—Diarrhoea—Epirubicin—testicular cancer	0.000287	0.000445	CcSEcCtD
Maprotiline—Vomiting—Methotrexate—testicular cancer	0.000285	0.000441	CcSEcCtD
Maprotiline—Rash—Methotrexate—testicular cancer	0.000283	0.000438	CcSEcCtD
Maprotiline—Dermatitis—Methotrexate—testicular cancer	0.000283	0.000437	CcSEcCtD
Maprotiline—Headache—Methotrexate—testicular cancer	0.000281	0.000435	CcSEcCtD
Maprotiline—Asthenia—Doxorubicin—testicular cancer	0.000279	0.000431	CcSEcCtD
Maprotiline—Dizziness—Epirubicin—testicular cancer	0.000278	0.00043	CcSEcCtD
Maprotiline—Pruritus—Doxorubicin—testicular cancer	0.000275	0.000425	CcSEcCtD
Maprotiline—Vomiting—Epirubicin—testicular cancer	0.000267	0.000413	CcSEcCtD
Maprotiline—Nausea—Methotrexate—testicular cancer	0.000266	0.000412	CcSEcCtD
Maprotiline—Diarrhoea—Doxorubicin—testicular cancer	0.000266	0.000411	CcSEcCtD
Maprotiline—Rash—Epirubicin—testicular cancer	0.000265	0.00041	CcSEcCtD
Maprotiline—Dermatitis—Epirubicin—testicular cancer	0.000264	0.000409	CcSEcCtD
Maprotiline—Headache—Epirubicin—testicular cancer	0.000263	0.000407	CcSEcCtD
Maprotiline—Dizziness—Doxorubicin—testicular cancer	0.000257	0.000398	CcSEcCtD
Maprotiline—Nausea—Epirubicin—testicular cancer	0.000249	0.000386	CcSEcCtD
Maprotiline—Vomiting—Doxorubicin—testicular cancer	0.000247	0.000382	CcSEcCtD
Maprotiline—Rash—Doxorubicin—testicular cancer	0.000245	0.000379	CcSEcCtD
Maprotiline—Dermatitis—Doxorubicin—testicular cancer	0.000245	0.000379	CcSEcCtD
Maprotiline—Headache—Doxorubicin—testicular cancer	0.000243	0.000377	CcSEcCtD
Maprotiline—Nausea—Doxorubicin—testicular cancer	0.000231	0.000357	CcSEcCtD
